Survival outcomes and treatment costs for patients with double-refractory chronic lymphocytic leukaemia (DR-CLL)

A Bloor, Cock E De, AJ Hatswell, R Wasiak, J Elvidge, C Stapelkamp, T Hadjivassileva, A Haiderali, J Delgado

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	British Journal of Haematology
Volume	169
Issue number	3
DOIs	https://doi.org/10.1111/bjh.13224
Publication status	Published - Nov 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{27894fe341064e208e9f409c190084b4,

title = "Survival outcomes and treatment costs for patients with double-refractory chronic lymphocytic leukaemia (DR-CLL)",

author = "A Bloor and De, {Cock E} and AJ Hatswell and R Wasiak and J Elvidge and C Stapelkamp and T Hadjivassileva and A Haiderali and J Delgado",

year = "2015",

month = nov,

doi = "10.1111/bjh.13224",

language = "English",

volume = "169",

journal = "British Journal of Haematology",

issn = "1365-2141",

publisher = "John Wiley & Sons Ltd",

number = "3",

}

TY - JOUR

T1 - Survival outcomes and treatment costs for patients with double-refractory chronic lymphocytic leukaemia (DR-CLL)

AU - Bloor, A

AU - De, Cock E

AU - Hatswell, AJ

AU - Wasiak, R

AU - Elvidge, J

AU - Stapelkamp, C

AU - Hadjivassileva, T

AU - Haiderali, A

AU - Delgado, J

PY - 2015/11

Y1 - 2015/11

U2 - 10.1111/bjh.13224

DO - 10.1111/bjh.13224

M3 - Article

SN - 1365-2141

VL - 169

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 3

ER -